7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Glaxo Group Limited patent solves the following problem:

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8633319 B2 deals with 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors.
The present invention relates to a compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potential use in the treatment of diseases resulting from inappropriate activation of mast and / or basophil cells, macrophages, and B-cells and related inflammatory response and tissue damage, for example, inflammatory disease, and / or allergic disorders, and cancer therapy, especially heme malignancies, chronic spontaneous urticaria and autoimmune conditions.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Process for making micro-sized protein particles

File for Quick & Easy Patent Protection with PowerPatent.

The Nanomaterials Technology Pte Ltd patent solves the following problem:

Modern medicine has relied heavily on synthetically made or chemical drugs to treat or prevent diseases and conditions in patients. However, in recent times there is more emphasis on the use of protein-based drugs (also known as biologics or biopharmaceuticals), to prevent and treat diseases and conditions, or pagpasig- restore or maintain the normal functions of the patient's body. Protein-based drugs are medicines based on proteins or portions of proteins such as peptides. Protein-based drugs have become more important in recent years with the advent of high throughput screening and proteomics.

Our analysis of this patent is as follows:

Nanomaterials Technology Pte Ltd’s patent US 8633152 B2 deals with Process for making micro-sized protein particles.
A process of making micro-sized protein particles comprising the steps of drying nano-sized protein particles suspended in a liquid medium under the condition of agglomerate of nano-sized protein particles and thus form micro-sized particles of protein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Drag reducing apparatus for a vehicle

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Aerodynamic Trailer Systems, Llc patent solves the following problem:

The present invention is a division of US application Ser. No. 12 / 594,662 at December 23, 2009, which in turn claims priority to US Provisional Patent Application Ser. No. 60 / 907,554 and May 5, 2007, and PCT / US08 / 059382 and May 4, 2008, incorporated here by reference.

Our analysis of this patent is as follows:

Aerodynamic Trailer Systems, Llc’s patent US 8622462 B2 deals with Drag reducing apparatus for a vehicle.
exposure consisted of a pair of inflatable substantially inelastic lobes. A claim can be mounted on each of the rear trailer door with a standard tractor-trailer unit. Each lobe can be inflated or deployed to give a flying substantially planar contour extending rearwardly back end of the car. The flying form lobes with strong and substantially planar outer surface for the wind up will be done in a series of internal rope and flag set extending substantially horizontally and vertically in a forest from a chasing side to the other side of each sheet. When the lobes shrink, the trailer door can be opened and decided on the side of the trailer in a conventional manner.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.